These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 4180662)

  • 1. Changes in blood coagulation and fibrinolysis in women receiving oral contraceptives. Comparison between treated and untreated women in a longitudinal study.
    Ygge J; Brody S; Korsan-Bengtsen K; Nilsson L
    Am J Obstet Gynecol; 1969 May; 104(1):87-98. PubMed ID: 4180662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of different systemic contraceptives on blood fibrinolysis.
    Brakman P; Sobrero AJ; Astrup T
    Am J Obstet Gynecol; 1970 Jan; 106(2):187-92. PubMed ID: 5410044
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor VII.
    Gjonnaess H; Fagerhol MK
    Scand J Haematol; 1974; 12(3):232-40. PubMed ID: 4831827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
    Shaaban MM; Elwan SI; el-Kabsh MY; Farghaly SA; Thabet N
    Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vascular pathology secondary to administration of estroprogestogens].
    Serban MD
    Stud Cercet Endocrinol; 1971; 22(2):99-112. PubMed ID: 4105297
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect on blood coagulation and fibrinolysis in women using norethisterone or a combination of ethinyloestradiol and quingestianol.
    Korsan-Bengtsen K; Larsson B
    Gynecol Obstet Invest; 1978; 9(6):312-8. PubMed ID: 754993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood coagulation and fibrinolysis in women receiving estrogen, gestagen and estrogen-gestagen-contraceptives (author's transl)].
    Lechner K; Hartmann E; Schneider WH; Spona J; Matt K
    Klin Wochenschr; 1976 May; 54(9):431-8. PubMed ID: 1271696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal steroids: effects on the vascular system.
    Solash J; Perez R; Keates JS; Ramasamy N; Stein H; Troyansky D; Ateyeh E; Jones JR; Srinivasan S; Sawyer PN
    Gynecol Invest; 1975; 6(6):329-36. PubMed ID: 1213600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the hormonal constitution variants in regard to the prescription of oral contraceptives].
    Krause J; Stamm H
    Bibl Gynaecol; 1970; 55():57-73. PubMed ID: 4109992
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
    Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
    Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation effects of oral contraception.
    Bonnar J
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1042-8. PubMed ID: 2960241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of an injectable progestogen contraceptive on blood coagulation and fibrinolysis.
    Whigham KA; Howie PW; Mack A; Prentice CR
    Br J Obstet Gynaecol; 1979 Oct; 86(10):806-9. PubMed ID: 508662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid.
    Jespersen J; Petersen KR; Skouby SO
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):396-403. PubMed ID: 2196812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies of 30 micrograms ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets.
    Daly L; Bonnar J
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):430-7. PubMed ID: 2142580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
    Petersen KR; Sidelmann J; Skouby SO; Jespersen J
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestational agents and blood coagulation. V. Changes induced by sequential oral contraceptive therapy.
    Mink IB; Courey NG; Niswander KR; Moore RH; Lillie MA; Ambrus JL
    Am J Obstet Gynecol; 1974 Jun; 119(3):401-5. PubMed ID: 4275088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.